In the past few years, Audacy (the former Entercom) has been a standout in the broadcast business with their special event focus tied to mental health. “I’m Listening” has aired annually in September and the company announced Monday that Genomind will join the as a sponsor.
Genomind offers consumer DNA testing that identifies factors that could affect mental and physical health. The two will be teaming up to promote Genomind’s testing in eight markets (Baltimore, Dallas, Houston, L.A., NYC, Philadelphia, San Diego and Washington, D.C.).
“Genomind works to help all of us understand our personal mental health wiring and give people new insights and tools to manage and promote personalized mental health and wellness,” said Kip Olmstead, President, Genomind. “Our partnership with Audacy scales our work allowing us to bring new mental health solutions to millions of Americans who may be suffering in silence or unsure of how to get started. Audacy’s leadership in mental health is impressive and we are thrilled to find such a progressive and purpose-driven partner.”
“Mental health awareness is a major area of focus for us and a crucial pillar of our companywide social impact platform, and we’re excited to further activate our commitment through this partnership with Genomind,” said Sarah Harris, Vice President, Social Impact, Audacy. “We recognize our significant influence and welcome the opportunity to use our voice, coupled with Genomind’s mental health expertise, innovations and technology, to help improve and save lives and continue our shared mission of ending the stigma of talking about mental health.”
Genomind will also sponsor Audacy’s 60-second “I’m Listening Daily Capsules”.